All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
05 2023
Historique:
received: 14 03 2023
accepted: 21 04 2023
medline: 8 5 2023
pubmed: 5 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

To investigate all-cause mortality, COVID-19 mortality and all-cause non-COVID-19 mortality in Qatar during the COVID-19 pandemic. A national, retrospective cohort analysis and national, matched, retrospective cohort studies were conducted between 5 February 2020 and 19 September 2022. There were 5025 deaths during a follow-up time of 5 247 220 person-years, of which 675 were COVID-19 related. Incidence rates were 0.96 (95% CI 0.93 to 0.98) per 1000 person-years for all-cause mortality, 0.13 (95% CI 0.12 to 0.14) per 1000 person-years for COVID-19 mortality and 0.83 (95% CI 0.80 to 0.85) per 1000 person-years for all-cause non-COVID-19 mortality. Adjusted HR, comparing all-cause non-COVID-19 mortality relative to Qataris, was lowest for Indians at 0.38 (95% CI 0.32 to 0.44), highest for Filipinos at 0.56 (95% CI 0.45 to 0.69) and was 0.51 (95% CI 0.45 to 0.58) for craft and manual workers (CMWs). Adjusted HR, comparing COVID-19 mortality relative to Qataris, was lowest for Indians at 1.54 (95% CI 0.97 to 2.44), highest for Nepalese at 5.34 (95% CI 1.56 to 18.34) and was 1.86 (95% CI 1.32 to 2.60) for CMWs. Incidence rate of all-cause mortality for each nationality group was lower than the crude death rate in the country of origin. Risk of non-COVID-19 death was low and was lowest among CMWs, perhaps reflecting the healthy worker effect. Risk of COVID-19 death was also low, but was highest among CMWs, largely reflecting higher exposure during first epidemic wave, before advent of effective COVID-19 treatments and vaccines.

Identifiants

pubmed: 37142299
pii: bmjgh-2023-012291
doi: 10.1136/bmjgh-2023-012291
pmc: PMC10163334
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: AAB has received institutional grant funding from Gilead Sciences unrelated to the work presented in this paper.

Références

N Engl J Med. 2021 Dec 9;385(24):e83
pubmed: 34614327
PLoS One. 2021 Oct 26;16(10):e0259152
pubmed: 34699571
PLoS Med. 2021 Dec 16;18(12):e1003879
pubmed: 34914711
Sci Rep. 2021 Jan 19;11(1):1811
pubmed: 33469048
Ann Intern Med. 2020 Dec 15;173(12):1004-1007
pubmed: 32915654
BMJ Open. 2020 Oct 7;10(10):e040428
pubmed: 33033033
PLoS One. 2022 Jul 19;17(7):e0271324
pubmed: 35853026
N Engl J Med. 2022 May 12;386(19):1804-1816
pubmed: 35263534
Nat Commun. 2022 Jun 2;13(1):3082
pubmed: 35654888
N Engl J Med. 2022 Jul 7;387(1):21-34
pubmed: 35704396
Nat Med. 2021 Dec;27(12):2136-2143
pubmed: 34728831
Injury. 2015 Sep;46(9):1806-13
pubmed: 25943291
PLoS One. 2017 Jun 20;12(6):e0179711
pubmed: 28632794
N Engl J Med. 2022 Oct 27;387(17):1620-1622
pubmed: 36198139
Int J Infect Dis. 2022 Nov;124:96-103
pubmed: 36218031
Sci Rep. 2021 Sep 14;11(1):18182
pubmed: 34521903
Int J Inj Contr Saf Promot. 2005 Mar;12(1):45-7
pubmed: 15814375
World J Surg. 2018 May;42(5):1346-1357
pubmed: 29063224
Open Forum Infect Dis. 2021 May 02;8(8):ofab221
pubmed: 34458388
Emerg Infect Dis. 2021 May;27(5):1343-1352
pubmed: 33900174
Diabetes Res Clin Pract. 2018 Mar;137:100-108
pubmed: 29175341
Occup Med (Lond). 1999 May;49(4):225-9
pubmed: 10474913
Lancet Infect Dis. 2023 Mar 10;:
pubmed: 36913963
Nat Commun. 2022 Aug 9;13(1):4675
pubmed: 35945213
Sci Rep. 2021 Mar 18;11(1):6233
pubmed: 33737535
EClinicalMedicine. 2021 May;35:100861
pubmed: 33937733
iScience. 2021 Jun 25;24(6):102646
pubmed: 34056566
J Glob Health. 2021 Jan 16;11:05005
pubmed: 33643638
Cardiology. 2019;143(1):37-48
pubmed: 31302648
N Engl J Med. 2021 Dec 30;385(27):2585-2586
pubmed: 34910864
BMJ Open Diabetes Res Care. 2022 Apr;10(2):
pubmed: 35443971
N Engl J Med. 2023 Feb 16;388(7):665-667
pubmed: 36652342
Popul Health Metr. 2019 Dec 30;17(1):20
pubmed: 31888689
World J Pediatr. 2011 Feb;7(1):41-4
pubmed: 20549413
J Epidemiol Glob Health. 2014 Dec;4(4):277-87
pubmed: 25455645
BMC Public Health. 2020 Jul 29;20(1):1186
pubmed: 32727594

Auteurs

Asma A AlNuaimi (AA)

Primary Health Care Corporation, Doha, Ad Dawhah, Qatar.

Hiam Chemaitelly (H)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University,Qatar Foundation - Education City, Doha, Qatar.
Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.

Sandy Semaan (S)

Primary Health Care Corporation, Doha, Ad Dawhah, Qatar.

Sawsan AlMukdad (S)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University,Qatar Foundation - Education City, Doha, Qatar.

Zaina Al-Kanaani (Z)

Hamad Medical Corporation, Doha, Qatar.

Anvar Hassan Kaleeckal (AH)

Hamad Medical Corporation, Doha, Qatar.

Ali Nizar Latif (AN)

Hamad Medical Corporation, Doha, Qatar.

Hamad Eid Al-Romaihi (HE)

Ministry of Public Health Qatar, Doha, Qatar.

Adeel A Butt (AA)

Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.
Hamad Medical Corporation, Doha, Qatar.
Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, USA.

Mohamed H Al-Thani (MH)

Ministry of Public Health Qatar, Doha, Qatar.

Roberto Bertollini (R)

Ministry of Public Health Qatar, Doha, Qatar.

Mariam AbdulMalik (M)

Primary Health Care Corporation, Doha, Ad Dawhah, Qatar.

Abdullatif Al-Khal (A)

Hamad Medical Corporation, Doha, Qatar.

Laith J Abu-Raddad (LJ)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar lja2002@qatar-med.cornell.edu.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University,Qatar Foundation - Education City, Doha, Qatar.
Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.
Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH